Elsevier

Journal of Gastrointestinal Surgery

Volume 6, Issue 2, March–April 2002, Pages 224-232
Journal of Gastrointestinal Surgery

Ssat annual meeting
Predictors of Microvascular Invasion in Patients with Hepatocellular Carcinoma Who Are Candidates for Orthotopic Liver Transplantation,☆☆

https://doi.org/10.1016/S1091-255X(01)00015-4Get rights and content

Abstract

Microvascular invasion affects survival after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). We sought to identify preoperative predictors of microvascular invasion in patients with HCC who were candidates for OLT. A cohort of 245 patients who underwent resection for HCC and fulfilled the criteria for OLT (i.e., single tumors ≤5 cm or no more than three tumors ≤3 cm) were identified from a multi-institutional database. Thirty-three percent of the patients had pathologic evidence of microvascular invasion. Thirty percent of patients with single tumors and 47% with multiple tumors had microvascular invasion (P = 0.04). Only 25% of patients with tumors smaller than ≤2 cm had microvascular invasion, compared to 31% and 50% with tumors greater than 2 to 4 cm or larger than 4 cm, respectively (P = 0.01). Tumor grade was highly correlated with microvascular invasion: 12% of patients with well-differentiated tumors had microvascular invasion, compared to 29% and 50% with moderately or poorly differentiated tumors, respectively (P < 0.001). The independent predictors of microvascular invasion were tumor size greater than 4 cm (odds ratio [OR], 3.0, 95% confidence interval [CI ], 1.2 to 7.1), and high tumor grade (OR, 6.3; 95% CI, 2.0 to 19.9). Tumor size and grade are strong predictors of microvascular invasion. A tumor biopsy with pathologic grading at the time of pretransplantation ablative therapy could improve selection of patients with HCC for OLT. ( J Gastrointest Surg 2002;6:224–232.)

Keywords

Hepatocellular carcinoma
liver transplantation
vascular invasion

Cited by (0)

Presented at the Forty-Second Annual Meeting of The Society for Surgery of the Alimentary Tract, Atlanta, Georgia, May 20–23, 2001.

☆☆

Supported by a T-32 Surgical Oncology Training Grant from the National Institutes of Health (N.F.E).

View Abstract